Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-23

Clinical Trial Update: Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating selenium supplementation in adults with moderate-to-severely active ulcerative colitis who are treated with advanced therapies; recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selenium supplementation (selenium)

Snippet

Sponsor: Northwestern University | Conditions: Ulcerative Colitis (UC) | Phase 2 | Status: RECRUITING